U.S. court temporarily blocks a competitor to AstraZeneca's Nexium

NEW YORK (Reuters) - A federal U.S. judge issued a temporary injunction against Hanmi Pharmaceutical Co Ltd on Friday, preventing the South Korean drugmaker from launching a close relative of AstraZeneca Plc's Nexium stomach-acid drug in the United States.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news